Alexander Seelenberger, MBA is the Chief Financial Officer of Vincerx. Mr Seelenberger has been a managing partner at Aurus Capital, a leading Latin American venture capital firm, heading its healthcare venture capital practice, since March 2009. In that role, Mr Seelenberger has co-founded and has been an executive director in several healthcare companies. From August 2007 to January 2009, Mr Seelenberger served as an associate at Athelera LLC, a New York-based boutique investment bank offering financial advisory services to clients in the United States, Latin America and Europe. Mr Seelenberger has served as a member of the board of directors of Andes Biotechnologies, a nucleic acid-based drug discovery and development company, since September 2009, Trigemina Holdings, Inc., a pharmaceutical company, since March 2012, Levita Magnetics, a magnetic surgical platform development company, since January 2012, Echopixel, Inc., a medical imaging device development company, since September 2012, and Algenis, a bioactive molecule development company, since December 2012.
Mr Seelenberger received a BBA in business from the University of Chile and an MBA with high distinction from Harvard Business School, where he graduated as a Baker Scholar.
What is Alexander A. Seelenberger's net worth?
The estimated net worth of Alexander A. Seelenberger is at least $19.23 as of August 11th, 2023. Mr. Seelenberger owns 1,514 shares of Vincerx Pharma stock worth more than $19 as of April 11th. This net worth evaluation does not reflect any other investments that Mr. Seelenberger may own. Learn More about Alexander A. Seelenberger's net worth.
How do I contact Alexander A. Seelenberger?
Has Alexander A. Seelenberger been buying or selling shares of Vincerx Pharma?
Alexander A. Seelenberger has not been actively trading shares of Vincerx Pharma in the last ninety days. Most recently, on Friday, August 11th, Alexander A. Seelenberger bought 525 shares of Vincerx Pharma stock. The stock was acquired at an average cost of $19.00 per share, with a total value of $9,975.00. Following the completion of the transaction, the insider now directly owns 1,514 shares of the company's stock, valued at $28,766. Learn More on Alexander A. Seelenberger's trading history.
Who are Vincerx Pharma's active insiders?